Go 6983
Based on 85 publication(s) in Google Scholar
Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ, PKCδ and PKCζ with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.23%
- CAS. Nr.: 133053-19-7
- Formel: C26H26N4O3
- Molecular Weight:442.51
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Go 6983
More- Nature. 2022 Jan;601(7894):600-605. [Abstract]
- Cancer Cell. 2024 Oct 14;42(10):1676-1692.e11. [Abstract]
- Cell. 2024 Nov 14;187(23):6566-6583.e22. [Abstract]
- Nat Methods. 2025 Mar;22(3):510-519. [Abstract]
- Immunity. 2021 Sep 14;54(9):2042-2056.e8. [Abstract]
- Cell Stem Cell. 2025 Mar 6;32(3):409-425.e8. [Abstract]
- Nat Cell Biol. 2026 Mar 13. [Abstract]
- Nat Protoc. 2026 Jan 26. [Abstract]
- Nat Protoc. 2023 May;18(5):1584-1620. [Abstract]
- Nat Commun. 2025 Feb 7;16(1):1429. [Abstract]
- Nat Commun. 2022 Nov 10;13(1):6796. [Abstract]
- Acta Pharm Sin B. 2025 Dec 29.
- Acta Pharm Sin B. 2021 Jan;11(1):71-88. [Abstract]
- Adv Sci (Weinh). 2024 Jan;11(4):e2304987. [Abstract]
- Theranostics. 2021 Jan 1;11(6):2612-2633. [Abstract]
- Exp Mol Med. 2021 Apr;53(4):572-590. [Abstract]
- Sci Adv. 2025 Dec 5;11(49):eaea3996. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2399215. [Abstract]
- Cell Death Dis. 2021 Nov 27;12(12):1113. [Abstract]
- Cell Death Dis. 2018 Feb 7;9(2):165. [Abstract]
- Sci China Life Sci. 2025 Apr 22. [Abstract]
- Cell Commun Signal. 2023 May 4;21(1):99. [Abstract]
- Phytomedicine. 2024 Apr:126:155200. [Abstract]
- Phytomedicine. 2022 Jun;100:154068. [Abstract]
- Free Radic Biol Med. 2021 Aug 20:172:213-225. [Abstract]
- Food Sci Hum Wellness. 2025.
- Redox Rep. 2025 Dec;30(1):2494314. [Abstract]
- Oncogene. 2021 Jul;40(30):4884-4893. [Abstract]
- Aging Cell. 2022 Mar;21(3):e13573. [Abstract]
- Elife. 2021 Mar 3:10:e60889. [Abstract]
- J Agric Food Chem. 2022 Apr 13;70(14):4328-4341. [Abstract]
- JCI Insight. 2026 Mar 23;11(6):e198846. [Abstract]
- Biochem Pharmacol. 2026 Jun 12;251(Pt 2):118163. [Abstract]
- Food Funct. 2021 May 11;12(9):3898-3918. [Abstract]
- Cells. 2022 Dec 26;12(1):91. [Abstract]
- CNS Neurosci Ther. 2024 Jun;30(6):e14754. [Abstract]
- Immunology. 2023 Sep;170(1):28-46. [Abstract]
- Int J Mol Sci. 2024 Oct 27;25(21):11548. [Abstract]
- Front Pharmacol. 2024 Jul 31:15:1389761. [Abstract]
- Cell Mol Neurobiol. 2020 Nov;40(8):1253-1269. [Abstract]
- Int Immunopharmacol. 2024 Oct 25;143(Pt 2):113468. [Abstract]
- BMC Biol. 2023 Mar 8;21(1):52. [Abstract]
- J Cell Mol Med. 2021 Jun;25(11):5238-5249. [Abstract]
- Oncol Res. 2025 Nov 27;33(12):3973-3989. [Abstract]
- J Inflamm Res. 2025 Apr 30:18:5759-5775. [Abstract]
- J Funct Foods. 2022, 99: 105358.
- Proteomics. 2026 May;26(5):69-85. [Abstract]
- Sci Rep. 2017 Oct 19;7(1):13571. [Abstract]
- Microbiol Spectr. 2022 Oct 26;10(5):e0105622. [Abstract]
- Cell Signal. 2025 Mar 29:111781. [Abstract]
- J Proteome Res. 2025 Oct 23. [Abstract]
- J Nat Prod. 2021 Apr 23;84(4):1022-1033. [Abstract]
- Thromb Res. 2024 Nov 7:244:109210. [Abstract]
- Front Oncol. 2021 Jun 21:11:663778. [Abstract]
- Cell Biol Int. 2020 Mar;44(3):838-847. [Abstract]
- FEBS Lett. 2024 Feb;598(4):400-414. [Abstract]
- Arch Biochem Biophys. 2020 Jul 15;687:108375. [Abstract]
- Diabetes Metab Syndr Obes. 2019 Nov 4;12:2289-2302. [Abstract]
- J Appl Toxicol. 2016 Nov;36(11):1409-17. [Abstract]
- Microvasc Res. 2023 Mar:146:104468. [Abstract]
- Vet Microbiol. 2016 Aug 30:192:26-33. [Abstract]
- Theriogenology. 2019 Oct 15:138:84-93. [Abstract]
- Korean J Physiol Pharmacol. 2022 Nov 1;26(6):469-478. [Abstract]
- Biochem Biophys Res Commun. 2018 Sep 3;503(1):62-70. [Abstract]
- Reprod Fertil Dev. 2020 Mar;32(5):522-530. [Abstract]
- Gen Comp Endocrinol. 2026 Mar:379:114913. [Abstract]
- Blood Cells Mol Dis. 2024 Jan:104:102798. [Abstract]
- Biol Pharm Bull. 2023;46(6):864-868. [Abstract]
- Rep Biochem Mol Biol. 2021 Jul;10(2):314-326. [Abstract]
- SSRN. 2026 May 20.
- medRxiv. 2026 Mar 7.
- bioRxiv. 2025 Dec 24.
- bioRxiv. 2025 Nov 7.
- bioRxiv. 2025 Nov 5:2025.11.05.684799. [Abstract]
- Patent. US20250295610A1.
- University of Pittsburgh. 2025.
- Methods Mol Biol. 2025 May 22. [Abstract]
- SSRN. 2025 May 27.
- bioRxiv. 2025 January 15.
- SSRN. 2024 May 6.
- bioRxiv. 2024 May 2.
- Research Square Preprint. 2024 Apr 19.
- bioRxiv. 2024 Feb 27.
- Research Square Print. August 24th, 2022.
- Research Square Preprint. 2021 Oct.
-
RT-PCR
-
Flow Cytometry
-
WB
-
WB
-
WB
Biologische Aktivität
|
PKCγ 6 nM (IC50) |
PKCα 7 nM (IC50) |
PKCβ 7 nM (IC50) |
PKCδ 10 nM (IC50) |
PKCζ 60 nM (IC50) |
PKCμ 20000 nM (IC50) |
Go 6983 inhibits PKCμ with IC50 of 20 μM, and the pther PKC isoenzymes can be suppressed by Go 6983 with IC50 values from 7 to 60 nM[1]. Go 6983 (100 nM) significantly reduces PMN adherence to the endothelium and infiltration into the myocardium compared with I/R + PMN hearts, and significantly inhibits superoxide release from PMNs by 90 +/- 2% in rat hearts[2]. Go 6983 (200 nM) has a reduced cardioprotective effect compared with the cardioprotective Go 6983 concentrations (50 and 100 nM) despite inhibiting PMN superoxide release by 99%[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 133053-19-7
-
Appearance Solid
-
Molecular Weight 442.51
-
Formel C26H26N4O3
-
Color Pink to red
-
SMILES
O=C(C(C1=CN(CCCN(C)C)C2=C1C=C(OC)C=C2)=C3C4=CNC5=C4C=CC=C5)NC3=O
-
Synonyms
Gö 6983; Goe 6983
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (85)
-
Journal Impact Factor
-
Most Recent
-
Nature
2022 Jan;601(7894):600-605. PMID: 34856602 -
Cancer Cell
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer. [Abstract]2024 Oct 14;42(10):1676-1692.e11. PMID: 39303726 -
Cell
2024 Nov 14;187(23):6566-6583.e22. PMID: 39332412 -
Nat Methods
Challenging the Astral mass analyzer to quantify up to 5,300 proteins per single cell at unseen accuracy to uncover cellular heterogeneity. [Abstract]2025 Mar;22(3):510-519. PMID: 39820751 -
Immunity
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis. [Abstract]2021 Sep 14;54(9):2042-2056.e8. PMID: 34407391 -
Cell Stem Cell
Modeling early gastrulation in human blastoids with DNA methylation patterns of natural blastocysts. [Abstract]2025 Mar 6;32(3):409-425.e8. PMID: 39814012 -
Nat Cell Biol
2026 Mar 13. PMID: 41826695 -
Nat Protoc
2026 Jan 26. PMID: 41588252 -
Nat Protoc
2023 May;18(5):1584-1620. PMID: 36792779 -
Nat Commun
2025 Feb 7;16(1):1429. PMID: 39920102
Go 6983 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 7;16(1):1429. [Abstract]
g-j. The effects of JNK (JNK-IN-8) (25 nM) and PKC (Go 6983) (100 nM) inhibition on the expression of Cxcl10 and Ccl4 in MC38 and Panc02 cells.
Go 6983 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 7;16(1):1429. [Abstract]
FACS analysis of CD8+ T-cell proliferation (CFSE low) in cultured with conditioned media derived from MC38 cells treated with WNT11 and inhibitors of CAMKII (CAMKII-IN-1)(100 nM), JNK (JNK-IN-8)(25 nM) and PKC (Go 6983)(100 nM) as indicated.
-
Nat Commun
Maprotiline restores ER homeostasis and rescues neurodegeneration via Histamine Receptor H1 inhibition in retinal ganglion cells. [Abstract]2022 Nov 10;13(1):6796. PMID: 36357388 -
-
Acta Pharm Sin B
Activated PKB/GSK-3 β synergizes with PKC- δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I. [Abstract]2021 Jan;11(1):71-88. PMID: 33532181 -
Adv Sci (Weinh)
Automated, High-Throughput Phenotypic Screening and Analysis Platform to Study Pre- and Post-Implantation Morphogenesis in Stem Cell-Derived Embryo-Like Structures. [Abstract]2024 Jan;11(4):e2304987. PMID: 37991133 -
Theranostics
CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3. [Abstract]2021 Jan 1;11(6):2612-2633. PMID: 33456563 -
Exp Mol Med
Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis. [Abstract]2021 Apr;53(4):572-590. PMID: 33811247 -
Sci Adv
2025 Dec 5;11(49):eaea3996. PMID: 41337593 -
Gut Microbes
Enterotoxigenic Escherichia coli heat labile enterotoxin affects neutrophil effector functions via cAMP/PKA/ERK signaling. [Abstract]2024 Jan-Dec;16(1):2399215. PMID: 39284098 -
Cell Death Dis
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. [Abstract]2021 Nov 27;12(12):1113. PMID: 34839358 -
Cell Death Dis
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG. [Abstract]2018 Feb 7;9(2):165. PMID: 29416003
Go 6983 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 Feb 7;9(2):165. [Abstract]
Western blot analysis of MCF-7 cells treated with Tan IIA at the specified concentrations for the expression of cytosolic PKC isoforms. The compound Go 6983 (GO, 20 μM) is included as a positive control.
-
Sci China Life Sci
Maternal transcription factor OTX2 directly induces SETD1A and promotes embryonic genome activation in human pre-implantation embryos. [Abstract]2025 Apr 22. PMID: 40285911 -
Cell Commun Signal
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy. [Abstract]2023 May 4;21(1):99. PMID: 37143083 -
Phytomedicine
Sinapine targeting PLCβ3 EF hands disrupts Gαq-PLCβ3 interaction and ameliorates cardiovascular diseases. [Abstract]2024 Apr:126:155200. PMID: 38387273 -
Phytomedicine
Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation. [Abstract]2022 Jun;100:154068. PMID: 35358930 -
Free Radic Biol Med
Lipid overload impairs hepatic VLDL secretion via oxidative stress-mediated PKCδ-HNF4α-MTP pathway in large yellow croaker (Larimichthys crocea). [Abstract]2021 Aug 20:172:213-225. PMID: 34116177 -
-
Redox Rep
Norepinephrine promotes oxidative stress in vascular adventitial fibroblasts via PKC/NFκB-mediated NOX2 upregulation. [Abstract]2025 Dec;30(1):2494314. PMID: 40269356 -
Oncogene
2021 Jul;40(30):4884-4893. PMID: 34163029 -
Aging Cell
Gamma frequency light flicker regulates amyloid precursor protein trafficking for reducing β-amyloid load in Alzheimer's disease model. [Abstract]2022 Mar;21(3):e13573. PMID: 35199454 -
Elife
Dynamic Na+/H+ exchanger 1 (NHE1) - calmodulin complexes of varying stoichiometry and structure regulate Ca2+-dependent NHE1 activation. [Abstract]2021 Mar 3:10:e60889. PMID: 33655882 -
J Agric Food Chem
Isolation, Identification, and Immunomodulatory Mechanism of Peptides from Lepidium meyenii (Maca) Protein Hydrolysate. [Abstract]2022 Apr 13;70(14):4328-4341. PMID: 35357828 -
JCI Insight
Targeting PI3Kγ anchoring enhances CFTR membrane localization and modulator efficacy via PKD1. [Abstract]2026 Mar 23;11(6):e198846. PMID: 41869727 -
Biochem Pharmacol
Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen. [Abstract]2026 Jun 12;251(Pt 2):118163. PMID: 42285368 -
Food Funct
Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. [Abstract]2021 May 11;12(9):3898-3918. PMID: 33977953 -
Cells
12- O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP. [Abstract]2022 Dec 26;12(1):91. PMID: 36611885 -
CNS Neurosci Ther
2024 Jun;30(6):e14754. PMID: 38884369 -
Immunology
Deficiency of angiopoietin-like 4 enhances CD8+ T cell bioactivity via metabolic reprogramming for impairing tumour progression. [Abstract]2023 Sep;170(1):28-46. PMID: 37094816 -
Int J Mol Sci
Platelet Glycoprotein Ibα Cytoplasmic Tail Exacerbates Thrombosis During Bacterial Sepsis. [Abstract]2024 Oct 27;25(21):11548. PMID: 39519103 -
Front Pharmacol
N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis. [Abstract]2024 Jul 31:15:1389761. PMID: 39144634 -
Cell Mol Neurobiol
Protective Effects of Hyperbaric Oxygen Therapy on Brain Injury by Regulating the Phosphorylation of Drp1 Through ROS/PKC Pathway in Heatstroke Rats. [Abstract]2020 Nov;40(8):1253-1269. PMID: 32043174 -
Int Immunopharmacol
PKCδ modulates SP1 mediated mitochondrial autophagy to exacerbate diacetylmorphine-induced ferroptosis in neurons. [Abstract]2024 Oct 25;143(Pt 2):113468. PMID: 39490143 -
BMC Biol
Temperature-induced embryonic diapause in chickens is mediated by PKC-NF-κB-IRF1 signaling. [Abstract]2023 Mar 8;21(1):52. PMID: 36882743 -
J Cell Mol Med
Photobiomodulation therapy promotes the ATP-binding cassette transporter A1-dependent cholesterol efflux in macrophage to ameliorate atherosclerosis. [Abstract]2021 Jun;25(11):5238-5249. PMID: 33951300 -
Oncol Res
TROP-2 Promotes Cell Proliferation via the AKT-Mediated PKC α Pathway and Is a Novel Target for Antibody-Drug Conjugates in Penile Carcinoma. [Abstract]2025 Nov 27;33(12):3973-3989. PMID: 41425706 -
J Inflamm Res
2025 Apr 30:18:5759-5775. PMID: 40322534 -
-
Proteomics
Dynamic Phosphoproteomic Profiling Captured Early Signaling Events for Cold Acclimation in Larval Zebrafish. [Abstract]2026 May;26(5):69-85. PMID: 41906457 -
Sci Rep
Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation. [Abstract]2017 Oct 19;7(1):13571. PMID: 29051621 -
Microbiol Spectr
2022 Oct 26;10(5):e0105622. PMID: 36000889 -
Cell Signal
Annexin A2 binds the 3'-UTR of H2AX mRNA and regulates histone-H2AX-derived hypoxia-inducible factor 1-alpha activation. [Abstract]2025 Mar 29:111781. PMID: 40164417 -
J Proteome Res
Chemoproteomics Reveals FAM114A2 as a Functional Target of Wikstroelide E for Reversal of HIV-1 Latency. [Abstract]2025 Oct 23. PMID: 41131870 -
J Nat Prod
Discovering the Mechanisms of Wikstroelide E as a Potential HIV-Latency-Reversing Agent by Transcriptome Profiling. [Abstract]2021 Apr 23;84(4):1022-1033. PMID: 33721994 -
Thromb Res
The role of protein kinase C and the glycoprotein Ibα cytoplasmic tail in anti-glycoprotein Ibα antibody-induced platelet apoptosis and thrombocytopenia. [Abstract]2024 Nov 7:244:109210. PMID: 39541612 -
Front Oncol
PDE2 Inhibits PKA-Mediated Phosphorylation of TFAM to Promote Mitochondrial Ca2+-Induced Colorectal Cancer Growth. [Abstract]2021 Jun 21:11:663778. PMID: 34235078 -
Cell Biol Int
2020 Mar;44(3):838-847. PMID: 31814221 -
FEBS Lett
Mdm2-mediated ubiquitination of PKCβII is responsible for insulin-induced heterologous desensitization of dopamine D3 receptor. [Abstract]2024 Feb;598(4):400-414. PMID: 38302840 -
Arch Biochem Biophys
Identification and characterization of human PEIG-1/GPRC5A as a 12-O-tetradecanoyl phorbol-13-acetate (TPA) and PKC-induced gene. [Abstract]2020 Jul 15;687:108375. PMID: 32339486 -
Diabetes Metab Syndr Obes
Essential Role Of High Glucose-Induced Overexpression Of PKCβ And PKCδ In GLP-1 Resistance In Rodent Cardiomyocytes. [Abstract]2019 Nov 4;12:2289-2302. PMID: 31807042 -
J Appl Toxicol
2,3,7,8-tetrachlorodibenzo-p-dioxin exposure influence the expression of glutamate transporter GLT-1 in C6 glioma cells via the Ca(2+) /protein kinase C pathway. [Abstract]2016 Nov;36(11):1409-17. PMID: 26988466
Go 6983 purchased from MedChemExpress. Usage Cited in: J Appl Toxicol. 2016 Nov;36(11):1409-17. [Abstract]
Protein levels of GLT-1 analyzed by Western blotting in C6 cells then treated with TCDD for 12 h. Cells are pre-treated with Ca2+-signaling blocker BAY-a-1040 (25 nM) for 30min before TCDD stimulation. The PKC inhibitor staurosporine (10 nM) and Go 6983 (1 μM) is applied 2 h before adding TCDD.
Go 6983 purchased from MedChemExpress. Usage Cited in: J Appl Toxicol. 2016 Nov;36(11):1409-17. [Abstract]
Quantitative analysis of the intensity of GLT-1 expression relative to GAPDH in the indicated groups. Cells are pre-treated with Ca2+-signaling blocker BAY-a-1040 (25 nM) for 30min before TCDD stimulation. The PKC inhibitor staurosporine (10 nM) and Go 6983 (1 μM) is applied 2 h before adding TCDD.
Go 6983 purchased from MedChemExpress. Usage Cited in: J Appl Toxicol. 2016 Nov;36(11):1409-17. [Abstract]
Immunofluorescence staining of PKC after pre-treatment with the Ca2+-signaling blocker and the PKC inhibitor. PKC is enriched in cytoplasmor perinucleus in untreated C6 cells (a-c), Go 6983-treated cells (g-i) or BAY-a-1040-treated cells (m-o). TCDD induces PKC translocation to the membrane in C6 glioma cells (d-f ).
-
Microvasc Res
Hypoglycaemia aggravates impaired endothelial-dependent vasodilation in diabetes by suppressing endothelial nitric oxide synthase activity and stimulating inducible nitric oxide synthase expression. [Abstract]2023 Mar:146:104468. PMID: 36513147 -
Vet Microbiol
The role of Ca(2+) mediated signaling pathways on the effect of taurine against Streptococcus uberis infection. [Abstract]2016 Aug 30:192:26-33. PMID: 27527761
Go 6983 purchased from MedChemExpress. Usage Cited in: Vet Microbiol. 2016 Aug 30:192:26-33. [Abstract]
Effect of PKC inhibitor on NF-kB DNA binding activity and NFAT inhibitor on NFATc1 DNA binding activity. Lane N is negative control; lane 1 is control group; lane 2 is S. uberis group; lane 3 is pre-treated with 2 μM Go 6983; lane 4 is pre-treated with 5 μM Go 6983; lane 5 is pre-treated with 10 μM Go 6983.
-
Theriogenology
Influence of Wilms' tumor suppressor gene WT1 on bovine Sertoli cells polarity and tight junctions via non-canonical WNT signaling pathway. [Abstract]2019 Oct 15:138:84-93. PMID: 31302435 -
Korean J Physiol Pharmacol
The WNT/Ca2+ pathway promotes atrial natriuretic peptide secretion by activating protein kinase C/transforming growth factor-β activated kinase 1/activating transcription factor 2 signaling in isolated beating rat atria. [Abstract]2022 Nov 1;26(6):469-478. PMID: 36302622 -
Biochem Biophys Res Commun
Gö6983 attenuates titanium particle-induced osteolysis and RANKL mediated osteoclastogenesis through the suppression of NFκB/JNK/p38 pathways. [Abstract]2018 Sep 3;503(1):62-70. PMID: 29856998
Go 6983 purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2018 Sep 3;503(1):62-70. [Abstract]
BMMs are incubated in serum-free medium and pretreated with or without Go6983 (0, 2.5 μM) for 4 h. Next, the BMMs are stimulated by RANKL (50 ng/mL) for the indicated times (0, 15, 30, 60 min). Additionally, the BMM lysates are analyzed by western blotting.
-
Reprod Fertil Dev
Wilms' tumour 1 (WT1) negatively regulates the expression of connexin 43 via a non-canonical Wnt signalling pathway in cultured bovine Sertoli cells. [Abstract]2020 Mar;32(5):522-530. PMID: 32023428 -
Gen Comp Endocrinol
Characterization of serotonin receptors Aj5-HTR2 and Aj5-HTR7 reveals potential roles in circadian regulation of Apostichopus japonicus. [Abstract]2026 Mar:379:114913. PMID: 41819218 -
Blood Cells Mol Dis
2024 Jan:104:102798. PMID: 37813040 -
Biol Pharm Bull
Inhibition of TRPC4/5 Channel Is Effective in Protecting against Histamine-Induced Hyperpermeability by Blocking Ca2+ Influx in Lung Microvascular Endothelial Cells. [Abstract]2023;46(6):864-868. PMID: 37258152 -
Rep Biochem Mol Biol
Signaling Pathway in the Osmotic Resistance Induced by Angiotensin II AT2 Receptor Activation in Human Erythrocytes. [Abstract]2021 Jul;10(2):314-326. PMID: 34604421 -
-
-
-
-
bioRxiv
2025 Nov 5:2025.11.05.684799. PMID: 41279964 -
-
-
Methods Mol Biol
Generation of Human Naïve Pluripotent Stem Cell-Derived Blastoids in Thermoformed Microwell Platforms. [Abstract]2025 May 22. PMID: 40397283 -
-
-
-
-
-
-
-
Lösungsmittel & Löslichkeit
DMSO : 100 mg/mL (225.98 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.65 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (5.65 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protokoll
Phosphorylation reactions are carried out in a total volume of 100 μL, containing buffer C (50 mM Tris-HCl, pH 7.5, 10 mM β-mercaptoethanol), 4 mM MgCl2, 10 μg PS, 100 nM TPA, 5 μL of a Sf158 cell extract as a source of recombinant PKCμ or of Sf9 cell extracts as a source of other recombinant PKC isoenzymes, 10 μg of syntide 2 as substrate, and 35 μM ATP containing 1 μCi [γ-32P]ATP. In some experiments, PS and TPA are omitted or various inhibitors at concentrations indicated in the text are added. After incubation for 10 min at 30°C, the reaction is terminated by transferring 50 μL of the assay mixture onto a 20 mm square piece of phosphocellulose paper, which is washed 3 times in deionized water and twice in acetone. The radioactivity on each paper is determined by liquid scintillation counting.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Reinheit & Dokumentation
-
Data Sheet (282 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Gschwendt M, et al. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett, 1996, 392(2), 77-80. [Content Brief]
[2]. Peterman EE, et al. G0 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion. J Cardiovasc Pharmacol, 2004, 43(5), 645-656. [Content Brief]
[3]. Young LH, et al. G0 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury. Cardiovasc Drug Rev, 2005, 23(3), 255-272. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2598 mL | 11.2992 mL | 22.5984 mL | 56.4959 mL |
| 5 mM | 0.4520 mL | 2.2598 mL | 4.5197 mL | 11.2992 mL | |
| 10 mM | 0.2260 mL | 1.1299 mL | 2.2598 mL | 5.6496 mL | |
| 15 mM | 0.1507 mL | 0.7533 mL | 1.5066 mL | 3.7664 mL | |
| 20 mM | 0.1130 mL | 0.5650 mL | 1.1299 mL | 2.8248 mL | |
| 25 mM | 0.0904 mL | 0.4520 mL | 0.9039 mL | 2.2598 mL | |
| 30 mM | 0.0753 mL | 0.3766 mL | 0.7533 mL | 1.8832 mL | |
| 40 mM | 0.0565 mL | 0.2825 mL | 0.5650 mL | 1.4124 mL | |
| 50 mM | 0.0452 mL | 0.2260 mL | 0.4520 mL | 1.1299 mL | |
| 60 mM | 0.0377 mL | 0.1883 mL | 0.3766 mL | 0.9416 mL | |
| 80 mM | 0.0282 mL | 0.1412 mL | 0.2825 mL | 0.7062 mL | |
| 100 mM | 0.0226 mL | 0.1130 mL | 0.2260 mL | 0.5650 mL |